We hypothesized that in epileptic brains citric acid cycle intermediate levels may be deficient leading to hyperexcitability. Anaplerosis is the metabolic refilling of deficient metabolites. Our goal was to determine the anticonvulsant effects of feeding triheptanoin, the triglyceride of anaplerotic heptanoate. CF1 mice were fed 0-35% calories from triheptanoin. Body weights and dietary intake were similar in mice fed triheptanoin vs. standard diet. Triheptanoin feeding increased blood propionyl-carnitine levels, signifying its metabolism. 35%, but not 20%, triheptanoin delayed development of corneal kindled seizures. After pilocarpine-induced status epilepticus (SE), triheptanoin feeding increased the pentylenetetrazole tonic seizure threshold during the chronically epileptic stage. Mice in the chronically epileptic stage showed various changes in brain metabolite levels, including a reduction in malate. Triheptanoin feeding largely restored a reduction in propionyl-CoA levels and increased methylmalonyl-CoA levels in SE mice. In summary, triheptanoin was anticonvulsant in two chronic mouse models and increased levels of anaplerotic precursor metabolites in epileptic mouse brains. The mechanisms of triheptanoin's effects and its efficacy in humans suffering from epilepsy remain to be determined.
Introduction
Up to 30% of epileptic patients, especially children, are drugresistant and suffer from uncontrolled seizures. Evidence is increasing that epileptic disorders are linked to dysfunction of metabolic processes. For example, several studies show that manipulation of metabolic pathways and subsequently energy metabolism can be anticonvulsant. One of the few alternative and efficacious therapies for drug-resistant epilepsy is the ketogenic diet (Neal et al., 2008) , a strict high fat diet that is very difficult to adhere to. The exact mechanism of seizure control exerted by the ketogenic diet is still unclear, although changes in energy metabolism appear to play a role (Bough et al., 2006; Hartman et al., 2007) . Mild hypoglycemia and the replacement of glucose by "ketones" in energy metabolism may be important for the anticonvulsant effects. Also, it was recently found that fructose-1,6-bisphosphate (Lian et al., 2007) and 2-deoxy-Dglucose (Stafstrom et al., 2009; Garriga-Canut et al., 2006) , which both also alter energy metabolism by reducing glycolysis, are effective in several rodent seizure models. These are all promising new therapies that are based on altering metabolism to treat epilepsy.
We hypothesized that in epileptic brains the levels of citric acid cycle (CAC) intermediates may be deficient leading to hyperexcitability. The oxidation of acetyl-CoA by the CAC and subsequent oxidative phosphorylation by the electron transport chain produces the most ATP in aerobic metabolism. The CAC intermediates α-ketoglutarate and oxaloacetate are precursors for the neurotransmitters glutamate, GABA and aspartate. Increased neurotransmission, such as during seizures, could therefore reduce the levels of CAC intermediates and subsequently acetyl-CoA oxidation and energy production. Anaplerosis is the refilling of reduced metabolites, including deficient catalytic intermediates of the CAC (Hassel, 2000; Brunengraber and Roe, 2006) . It could therefore increase ATP production needed to keep neuronal membrane potentials stable and potentially prevent epileptic bursts.
Anaplerotic molecules include certain amino acids and odd chain fatty acids. Triheptanoin is the triglyceride of the anaplerotic C7 fatty acid heptanoate. Triheptanoin provides three anaplerotic propionylCoA molecules without overloading the system with nitrogen, sodium or acid. Triheptanoin has been successfully used as a dietary treatment for hereditary metabolic disorders in patients (Roe and Mochel, 2006; Roe et al., 2002; Mochel et al., 2005) . Heptanoate itself can enter the brain (Wang et al., 2007) . Moreover, the liver metabolizes heptanoate to the "C5 ketone" bodies β-hydroxypentanoate and β-ketopentanoate. These are taken up by the brain, most likely through monocarboxylate transporters (Mochel et al., 2005) . Each C5 ketone molecule is metabolized to one acetyl-CoA and one anaplerotic propionyl-CoA molecule. Alternatively, propionyl-CoA can be produced by β-oxidation of heptanoyl-CoA. Propionyl-CoA can replenish oxaloacetate via succinyl-CoA in rats (Kinman et al., 2006) . Thus, it can increase acetyl-CoA oxidation and ATP production. 
